Infliximab in psoriatic arthritis

Author： Anandarajah Allen P   Ritchlin Christopher T  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.2, Iss.1, 2007-02, pp. : 13-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?

By Tektonidou Maria   Skopouli Fotini  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 541-542

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment

By Brodszky V.   Pentek M.   Gulacsi L.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 5, 2008-01 ,pp. : 399-400

Informa Healthcare

Access to resources Recommend Favorite

Psoriatic arthritis and alpha-interferon

By Olivieri Ignazio   Padula A Ngela   Ciancio Giovanni   Civita Luca La  

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 3, 2001-05 ,pp. : 175-175

Informa Healthcare

Access to resources Recommend Favorite

Genetic epidemiology of psoriatic arthritis

By Ho Pauline   Barton Anne   Worthington Jane  

Modern Rheumatology, Vol. 14, Iss. 2, 2004-06 ,pp. : 91-100

Springer Publishing Company

Access to resources Recommend Favorite

Classification and categorisation of psoriatic arthritis

By Coates Laura   Helliwell Philip  

Clinical Rheumatology, Vol. 27, Iss. 10, 2008-10 ,pp. : 1211-1216

Springer Publishing Company

Access to resources Recommend Favorite